What Researchers Did
Researchers investigated the preliminary experience of hyperbaric oxygen therapy (HBO) in 8 out of 53 patients with benign intracranial hypertension (BIH), administering 100% oxygen at 2 atmospheres absolute daily for 15 days.
What They Found
In all 8 patients treated with hyperbaric oxygen, a gradual disappearance of signs and symptoms of elevated intracranial pressure was observed during the 15-day treatment period. However, no lasting effects of the treatment were seen after the therapy concluded.
Canadian Relevance
This study has no direct Canadian connection or specific relevance to the Canadian healthcare system.
Study Limitations
Key limitations include the very small sample size of only 8 patients receiving hyperbaric oxygen therapy and the observation of no lasting effects after treatment concluded.